Heyu Biological Technology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Heyu Biological Technology generated cash of -$292,300, which is less than the previous year. Cash used in financing activities reached the amount of $196,457 last year. Net change in cash is therefore $7,105.
Cash Flow
| 2013 | -981.21K | 2.39M | -1.14M |
|---|---|---|---|
| 2014 | -1.55M | 240.36K | -1.04K |
| 2015 | -378.37K | 0 | -52.75K |
| 2016 | -308.03K | 179.10K | -49.26K |
| 2017 | -41.3K | 0 | 41.3K |
| 2018 | -265.26K | 262.69K | 300.25K |
| 2019 | -546.62K | 0 | 595.28K |
| 2020 | -21.84K | 0 | 35.13K |
| 2021 | -141.14K | 0 | 162.41K |
| 2022 | -292.3K | 0 | 196.45K |
HYBT Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.32K | 5.48K | 95.52K | 37.55K | -262.69K | 0 | 178.18K | 609.31K | 1.92M | 1.65M |
Operating activities | ||||||||||
Net income | -265.57K | -163.02K | -753.14K | -540.01K | -247.77K | -54.11K | 0 | 0 | -498.81K | -3.68M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.06K | 18.03K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 149.95K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 149.95K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 1.31K | 31.52K | -110.44K | 0 | 0 | 0 | 0 | -993.26K | -36.47K |
Inventories | 0 | 8.86K | -52.76K | -421.53K | 0 | 0 | 0 | 0 | 2.71K | 1.97K |
Accounts payable | 15.98K | -515 | -62.82K | 94.74K | 3.81K | 12.81K | 0 | 0 | -2.55K | -728.58K |
Cash generated by operating activities | -292.3K | -141.14K | -21.84K | -546.62K | -265.26K | -41.3K | -308.03K | -378.37K | -1.55M | -981.21K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2K |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.63K | -4.67K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.80M |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 262.69K | 0 | 179.10K | 0 | 240.36K | 2.39M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -45.32K | -1.18M |
Cash used in financing activities | 196.45K | 162.41K | 35.13K | 595.28K | 300.25K | 41.3K | -49.26K | -52.75K | -1.04K | -1.14M |
Net Change In Cash | 7.10K | -1.16K | -90.03K | 57.96K | 300.25K | 0 | -178.18K | -431.12K | -1.31M | 273.02K |
Cash at end of period | 11.42K | 4.32K | 5.48K | 95.52K | 37.55K | 0 | 0 | 178.18K | 609.31K | 1.92M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |